| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Nov 11, 2014 |
|||||||||
AECOM
ACM
|
Q4 FY14 | $0.64 | $0.82 | $2.56B | $3.28B |
NYSE |
|||
D.R. Horton
DHI
|
Q4 FY14 | $0.45 | $0.48 | $2.47B | $2.64B |
NYSE |
|||
Fossil Group
FOSL
|
Q3 FY14 | $1.96 | $1.82 | $894.48M | $830.61M |
NASDAQ |
|||
|
Sabre
SABR
|
Q3 FY14 | $0.26 | $0.25 | $756.30M | $672.50M |
NASDAQ |
|||
|
SunOpta
STKL
|
- | $0.12 | $0.13 | $318.55M | $282.24M |
NASDAQ |
|||
|
Gevo
GEVO
|
Q3 FY14 | -$780.78 | -$1.08 K | $10.14M | $169M |
NASDAQ |
|||
|
Phibro Animal Health
PAHC
|
- | $0.51 | $0.36 | $187.46M | $128.68M |
NASDAQ |
|||
|
LGI Homes
LGIH
|
Q3 FY14 | $0.34 | $0.34 | $92.52M | $92.50M |
NASDAQ |
|||
|
MacroGenics
MGNX
|
Q3 FY14 | -$0.14 | -$0.42 | $18.28M | $55.15M |
NASDAQ |
|||
|
Supernus Pharmaceuticals
SUPN
|
- | -$0.20 | $0.45 | $52.49M | $48.45M |
NASDAQ |
|||
|
Inogen
INGN
|
Q3 FY14 | $0.11 | $0.06 | $29.39M | $27.28M |
NASDAQ |
|||
|
Comstock Holding Companies
CHCI
|
- | -$0.07 | - | $18.37M | - |
NASDAQ |
|||
|
Profire Energy
PFIE
|
Q2 FY15 | $0.04 | $0.04 | $15.72M | $15.72M |
NASDAQ |
|||
|
Stabilis Solutions
SLNG
|
Q3 FY14 | -$2.08 | $0.88 | $14.28M | - |
NASDAQ |
|||
|
Cyclacel Pharmaceuticals
CYCC
|
Q3 FY14 | -$791.92 | -$3.12 | $735K | $874.55K |
NASDAQ |
|||
|
Ideal Power
IPWR
|
Q3 FY14 | -$2.60 | -$2.40 | $289K | $304.62K |
NASDAQ |
|||
|
Cellectar Biosciences
CLRB
|
Q3 FY14 | -$100.00 | - | - | - |
NASDAQ |
|||
|
Larimar Therapeutics
LRMR
|
- | -$7.20 | -$11.07 | - | - |
NASDAQ |
|||
|
Fate Therapeutics
FATE
|
Q3 FY14 | -$0.30 | -$0.29 | - | - |
NASDAQ |
|||
|
Sage Therapeutics
SAGE
|
- | -$0.50 | -$0.47 | - | - |
NASDAQ |
|||
| Show 10 more companies | |||||||||
